Novo Nordisk shares are submitted after the trial of Cagrisema drug trial

Medical bottles and syringes are visible with the Novo Nordisk logo, which is displayed on the screen.

Nurphoto | Nurphoto | Gets the image

Shares Novo nordisk The fall on Monday, after the Danish pharmaceutical giant said his next-generation weight drugs were assisted by adult patients with overweight with type 2 diabetes decreased by 15.7% of his weight after 68 weeks.

The company’s shares at 11:10 in London decreased by 5.52%.

This broken news is updated.

Source link